Description
Disclaimer: This is a research chemical only. It’s not a medication, and it’s not approved for human or animal use outside of authorized studies
| Sequence | H‑His‑Aib‑Glu‑Gly‑Thr‑Phe‑Thr‑Ser‑Asp‑Val‑Ser‑Ser‑Tyr‑Leu‑Glu‑Gly‑Gln‑Ala‑Ala‑Lys(ε‑AEEAc‑AEEAc‑γ‑Glu‑17‑carboxyheptadecanoyl)‑Glu‑Phe‑Ile‑Ala‑Trp‑Leu‑Val‑Arg‑Gly‑Arg‑Gly‑OH (Semaglutide) |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Molecular Weight | ~4113.6 Da |
| PubChem CID | 56843331 |
| CAS # | 910463‑68‑2 |
Semaglutide is a long-acting GLP-1 receptor agonist under extensive investigation for its role in regulating appetite, blood glucose levels, and energy balance. Structurally modified for enhanced half-life and resistance to enzymatic degradation, Semaglutide mimics endogenous glucagon-like peptide-1 (GLP-1), a hormone central to glucose metabolism and satiety signaling.
Its extended duration of action allows for once-weekly experimental administration, making it favorable in long-term metabolic and endocrine research protocols.
Reviews
There are no reviews yet.